doi:10.1016/j.neuroscience.2006.05.061
The approach is intended to build on the mechanisms of existing incretin-based obesity medicines, including Lilly's dual GIP/GLP-1 agonist tirzepatide
Early screening for psychiatric risk, emotion-driven eating, and motivation can inform individualized care plans, while digital tools such as ecological momentary assessment and ecological momentary interventions may support adherence and relapse prevention across treatment phases
Hormonal Influence: Emerging research suggests that gut bacteria can influence the production and regulation of various hormones, including those involved in appetite control, such as GLP-1 itself, and insulin sensitivity
This is a standard model for testing procognitive compounds
Neither form causes diabetes